Article citationsMore>>

Bizzarro, A., Guglielmi, V., Lomastro, R., Valenza, A., Lauria, A., Marra, C., Silveri, M.C., Tiziano, F.D., Brahe, C. and Masullo, C. (2010) BuChE K Variant Is Decreased in Alzheimer’s Disease Not in Fronto-Temporal Dementia. Journal of Neural Transmission, 117, 377-383.
http://dx.doi.org/10.1007/s00702-009-0358-y

has been cited by the following article:

• TITLE: Prevalence of Wild-Type Butyrylcholinesterase Genotype in Patients with Alzheimer’s Dementia

  AUTHORS: Beate Mueller, Georg Adler

  KEYWORDS: Butyrylcholinesterase, Alzheimer’s Disease, Genotype

  JOURNAL NAME: World Journal of Neuroscience, Vol.5 No.3, June 2, 2015

  ABSTRACT: Approximately, two-thirds patients with Alzheimer’s disease (AD) are reported to have homozygous wild-type butyrylcholinesterase (BuChE) gene expression. It is associated with a higher rate of hydrolysis of acetylcholine, which ultimately leads to increase in the levels of BuChE in advanced stages of the disease. Rivastigmine, a dual inhibitor of acetylcholinesterase (AChE) and BuChE, might be of additional benefit in patients with AD with wild-type BuChE allele.